Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
 |
Biochim Biophys Acta. 1999 Nov 9;1461(1):103-12. Unique Identifier : AIDSLINE MED/20025447
Silberstein A; Mirzabekov T; Anderson WF; Rozenberg Y; Gene Therapy Laboratories, School of Medicine, University of; Southern California, 1441 EastLake Ave., Room 610, Los Angeles,; CA, USA.
Abstract: Inorganic ions are highly suitable markers for monitoring release of the inner content of liposomes. In the present study, a potassium (K(+)) selective electrode was used to evaluate the rate of K(+) release from large unilamellar vesicles (LUV). The developed method is highly sensitive, reproducible and inexpensive. Since the K(+) ion is smaller than other markers conventionally used, the method described is more sensitive than one of the standard methods that uses ANTS/DPX. In addition, the method allows us to expand the set of molecules used as inner content markers to a lower size range. The experimental protocol we described contains improvements on the method of Breukink et al. (Biochemistry, 36 (1997) 6968). Our developed method was applied to compare the destabilizing activities of two amphipathic peptides of natural origin (Melittin and HIV env seg I, 827-851) and of two artificial peptides (Hels 7:11 and 9:9) synthesized de novo by Kiyota et al. (Biochemistry, 35 (1996) 13196). The tested peptides released 20% of the liposomal K(+) in 1 min at peptide-to-lipid ratio of a few mmol per mol of total lipids (LUV sized to 0.2 micrometer, molar composition is POPC:POPS:Chol 2:2:1).
000330
A0030878
Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .